SEROCONVERSION FAILURE AFTER HEPATITIS-B VACCINATION - EFFECT OF ADDITIONAL VACCINATIONS

被引:14
|
作者
JILG, W
SCHMIDT, M
DEINHARDT, F
机构
[1] Von Pettenkofer Inst. Hygiene, Universitat Munchen, W-8000 Munchen 2
关键词
D O I
10.1055/s-2008-1065189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One to three repeat vaccinations were undertaken in 63 persons (32 males, 31 females; mean age 29 [17-59] years) who had not or inadequately responded to basal immunization with hepatitis B vaccine (47 non- and 16 hyporesponders). After re-vaccination, 12 of the 47 nonresponders and 11 of 16 hyporesponders formed specific antibodies against hepatitis B surface antigen, anti-HBs, at concentrations above 10 IU/l. Six of 14 persons who had not responded to the first repeat vaccination reached anti-HBs concentrations above 10 U/l after a further injection. Vaccination response was age-dependent. The median age of those subjects who responded to the first re-vaccination was 27 (19-45) years, while the nonresponders' median age was 34 (22-59) years (P < 0.05). Re-vaccination also raised initially low anti-HBs values. These results indicate that some of the nonresponders can obtain reliable protection by revaccination(s).
引用
收藏
页码:1545 / 1548
页数:4
相关论文
共 50 条
  • [41] EFFECT OF A HEPATITIS-B VACCINATION PROGRAM ON THE PREVALENCE OF HEPATITIS-B VIRUS-INFECTION
    MAHONEY, FJ
    WOODRUFF, BA
    ERBEN, JJ
    COLEMAN, PJ
    REID, EC
    SCHATZ, GC
    KANE, MA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 203 - 207
  • [42] SEROCONVERSION RATES AFTER INTRAGLUTEAL OR INTRADELTOID ADMINISTRATION OF HEPATITIS-B VACCINE
    STEINMANN, J
    ARNOLD, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 110 (38) : 1472 - 1473
  • [43] PERSISTENCE OF ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN AFTER VACCINATION WITH HEPATITIS-B VACCINE
    TAYLOR, PE
    STEVENS, CE
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A90 - A90
  • [44] SEROCONVERSION AFTER ADDITIONAL VACCINE DOSES TO NONRESPONDERS TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTERED RECOMBINANT HEPATITIS-B VACCINE
    STRUVE, J
    ARONSSON, B
    FRENNING, B
    FORSGREN, M
    WEILAND, O
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (04) : 468 - 470
  • [45] THE ASSESSMENT OF IMMUNITY AGAINST HEPATITIS-B AFTER VACCINATION
    FRISCHNIGGEMEYER, W
    AMBROSCH, F
    HOFMANN, H
    [J]. JOURNAL OF BIOLOGICAL STANDARDIZATION, 1986, 14 (03): : 255 - 258
  • [46] HEPATITIS-B (HB) VACCINATION AFTER RENAL ALLOTRANSPLANTATION
    BINSWANGER, U
    GROB, P
    HOFMANN, J
    KEUSCH, G
    [J]. KIDNEY INTERNATIONAL, 1983, 24 (02) : 275 - 275
  • [47] HIV FALSE POSITIVITY AFTER HEPATITIS-B VACCINATION
    LEE, DA
    EBY, WC
    MOLINARO, GA
    [J]. LANCET, 1992, 339 (8800): : 1060 - 1060
  • [48] SEVERE ACUTE HEPATITIS-B INFECTION AFTER VACCINATION
    BALLINGER, AB
    CLARK, ML
    [J]. LANCET, 1994, 344 (8932): : 1292 - 1292
  • [49] INEFFECTIVENESS OF HEPATITIS-B VACCINATION FOR THE HEPATITIS-B CARRIER STATE
    IBER, FL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (07): : 830 - 830
  • [50] PERSISTENCE OF SPECIFIC ANTIBODIES AFTER HEPATITIS-B VACCINATION
    JILG, W
    SCHMIDT, M
    DEINHARDT, F
    [J]. JOURNAL OF HEPATOLOGY, 1988, 6 (02) : 201 - 207